Raleigh Capital Management Inc.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1911726
CARY, NC
Position in REGN
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$32,424
-$19,342 QoQ
Shares Held
52
-22.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,150
of 1,322 holders
Holding Since
Dec 2021
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Raleigh Capital Management Inc. holds $110,609 across 3 Biotechnology names. REGN ranks #2 (29.3% of the industry book) .
All Filings in REGN
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,424 | 52 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $51,766 | 67 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $49,399 | 64 | Shares | Sole | 2026-01-21 | |
| 2024-12-31 | $26,356 | 37 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $49,408 | 47 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $47,296 | 45 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $36,574 | 38 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $16,687 | 19 | Shares | Sole | 2024-02-21 | |
| 2023-09-30 | $6,583 | 8 | Shares | Sole | 2023-12-08 | |
| 2023-06-30 | $5,748 | 8 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $6,573 | 8 | Shares | Sole | 2023-05-22 | |
| 2021-12-31 | $3,789 | 6 | Shares | Sole | 2022-02-16 | |
| No filing history on record for this holder in this stock. | ||||||